| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | Director | Option to purchase Ordinary Shares | 1,144,686 | 01 Jul 2024 | Direct | ||
| TCR2 THERAPEUTICS INC. | Director | Stock Option (Right to Buy) | 0 | $0.7400 | 01 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 01 Jul 2024 | 1 | $0 | 4 | Director | 01 Jul 2024, 17:02 |
| ADAP | Adaptimmune Therapeutics PLC | 05 Jul 2023 | 3 | $0 | 4 | Director | 05 Jul 2023, 17:05 |
| ADAP | Adaptimmune Therapeutics PLC | 03 Jul 2023 | 1 | $0 | 4 | Director | 03 Jul 2023, 17:04 |
| ADAP | Adaptimmune Therapeutics PLC | 01 Jun 2023 | 0 | $0 | 3 | Director | 01 Jun 2023, 16:48 |
| /report/000110465923067046-hegde-priti-2023-06-01 | TCR2 THERAPEUTICS INC. | 01 Jun 2023 | 3 | $0 | 4 | Director | 01 Jun 2023, 16:18 |
| /report/000089924322039014-hegde-priti-2022-12-15 | TCR2 THERAPEUTICS INC. | 15 Dec 2022 | 1 | $0 | 4 | Director | 19 Dec 2022, 16:18 |
| /report/000120919121069029-hegde-priti-2021-12-09 | TCR2 THERAPEUTICS INC. | 09 Dec 2021 | 1 | $0 | 4 | Director | 10 Dec 2021, 15:29 |
| /report/000120919121053469-hegde-priti-2021-08-25 | TCR2 THERAPEUTICS INC. | 25 Aug 2021 | 1 | $0 | 4 | Director | 26 Aug 2021, 16:21 |
| /report/000120919121053466-hegde-priti-2021-08-25 | TCR2 THERAPEUTICS INC. | 25 Aug 2021 | 0 | $0 | 3 | Director | 26 Aug 2021, 16:15 |